Mouse Positron Emission Tomography Study of the Biodistribution of Gold Nanoparticles with Different Surface Coatings Using Embedded Copper-64

被引:46
作者
Frellsen, Anders F. [1 ,2 ]
Hansen, Anders E. [2 ,3 ,4 ,5 ]
Jolck, Rasmus I. [2 ]
Kempen, Paul J. [2 ]
Severin, Gregory W. [1 ]
Rasmussen, Palle H. [1 ]
Kjaer, Andreas [3 ,4 ,5 ]
Jensen, Andreas T. I. [1 ]
Andresen, Thomas L. [2 ]
机构
[1] Tech Univ Denmark, Hevesy Lab, Ctr Nucl Technol, DK-4000 Roskilde, Denmark
[2] Tech Univ Denmark, Ctr Nanomed & Theranost, DTU Nanotech, DK-2800 Lyngby, Denmark
[3] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark
[4] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark
[5] Univ Copenhagen, DK-2100 Copenhagen, Denmark
基金
欧洲研究理事会;
关键词
gold nanoparticles; copper-64; PET; intrinsic radiolabeling; coating materials; MACROMOLECULAR THERAPEUTICS; CELLULAR UPTAKE; PARTICLE-SIZE; CANCER; STABILITY; GROWTH; RADIOPHARMACEUTICALS; CIRCULATION; NUCLEATION; MONOLAYERS;
D O I
10.1021/acsnano.6b03144
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
By taking advantage of the ability of Cu-64 to bind nonspecifically to gold surfaces, we have developed a methodology to embed this radionuclide inside gold nanoparticles (AuNPs). Cu-64 enables the in vivo imaging of AuNPs by positron emission tomography (PET). AuNPs have a multitude of uses within health technology and are useful tools for general nanoparticle research. Cu-64-AuNPs were prepared by incubating AuNP seeds with (64)4CU(2+), followed by the entrapment of the radionuclide by grafting on a second layer of gold. This resulted in radiolabeling efficiencies of 53 +/- 6%. The radiolabel showed excellent stability when incubated with EDTA for 2 days (95% radioactivity retention) and showed no loss of Cu-64 when incubated with 50% mouse serum for 2 days. The methodology was chelator-free, removing traditional concerns over chelator instability and altered AuNP properties due to surface modification. Radiolabeled Cu-64-AuNP cores were prepared in biomedically relevant sizes of 20-30 nm and used to investigate the in vivo stability of three different AuNP coatings by PET imaging in a murine xenograft tumor model. We found the longest plasma half-life (T-1/2 about 9 h) and tumor accumulation (3.9%ID/g) to result from a polyethylene glycol coating, while faster elimination from the bloodstream was observed with both a Tween 20-stabilized coating and a zwitterionic coating based on a mixture of sulfonic acids and quaternary amines. In the in vivo model, the Cu-64 was observed to closely follow the AuNPs for each coating, again attributed to the excellent stability of the radiolabel.
引用
收藏
页码:9887 / 9898
页数:12
相关论文
共 59 条
[1]   The Gold Standard: Gold Nanoparticle Libraries To Understand the Nano-Bio Interface [J].
Alkilany, Alaaldin M. ;
Lohse, Samuel E. ;
Murphy, Catherine J. .
ACCOUNTS OF CHEMICAL RESEARCH, 2013, 46 (03) :650-661
[2]   Shape-Templated Growth of Au@Cu Nanoparticles [J].
Alvarez-Paneque, Alejandro F. ;
Rodriguez-Gonzalez, Benito ;
Pastoriza-Santos, Isabel ;
Liz-Marzan, Luis M. .
JOURNAL OF PHYSICAL CHEMISTRY C, 2013, 117 (06) :2474-2479
[3]   Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research [J].
Anderson, Carolyn J. ;
Ferdani, Riccardo .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (04) :379-393
[4]   Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography [J].
Bartholomae, Mark D. .
INORGANICA CHIMICA ACTA, 2012, 389 :36-51
[5]   Kinetically Controlled Seeded Growth Synthesis of Citrate-Stabilized Gold Nanoparticles of up to 200 nm: Size Focusing versus Ostwald Ripening [J].
Bastus, Neus G. ;
Comenge, Joan ;
Puntes, Victor .
LANGMUIR, 2011, 27 (17) :11098-11105
[6]   Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes [J].
Boswell, CA ;
Sun, XK ;
Niu, WJ ;
Weisman, GR ;
Wong, EH ;
Rheingold, AL ;
Anderson, CJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1465-1474
[7]   In vitro and in vivo characterization of 64Cu-labeled Abegrin™ a humanized monoclonal antibody against integrin αvβ3 [J].
Cai, Weibo ;
Wu, Yun ;
Chen, Kai ;
Cao, Qizhen ;
Tice, David A. ;
Chen, Xiaoyuan .
CANCER RESEARCH, 2006, 66 (19) :9673-9681
[8]   Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity [J].
Connor, EE ;
Mwamuka, J ;
Gole, A ;
Murphy, CJ ;
Wyatt, MD .
SMALL, 2005, 1 (03) :325-327
[9]   Nanoparticle therapeutics: an emerging treatment modality for cancer [J].
Davis, Mark E. ;
Chen, Zhuo ;
Shin, Dong M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :771-782
[10]   Gold nanoparticles in biomedical applications: recent advances and perspectives [J].
Dykman, Lev ;
Khlebtsov, Nikolai .
CHEMICAL SOCIETY REVIEWS, 2012, 41 (06) :2256-2282